会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • CROSS-CHANNEL NOISE DETECTOR IN IMPLANTABLE DEVICES
    • 交叉通道噪声检测器在可移植设备中
    • WO2010090896A1
    • 2010-08-12
    • PCT/US2010/022028
    • 2010-01-26
    • CARDIAC PACEMAKERS, INC.LI, DanPERSCHBACHER, David, L.
    • LI, DanPERSCHBACHER, David, L.
    • A61N1/37A61N1/08
    • A61N1/3704A61N1/3718A61N1/3925
    • An apparatus comprises a primary cardiac signal sensing circuit to sense a first cardiac signal, a secondary cardiac signal sensing to sense a second cardiac signal, and an arrhythmia detection circuit. The primary sensing circuit includes at least first and second implantable electrodes, and the secondary sensing circuit includes a third implantable electrode to deliver high-energy shock therapy. The arrhythmia detection circuit detects tachyarrhythmia using the primary sensing circuit, determines correspondence between events sensed with the primary sensing circuit and events sensed with the secondary sensing circuit, and deems whether a detected rhythm is indicative of noise or is indicative of an arrhythmia according to the determined correspondence.
    • 一种装置包括用于感测第一心脏信号的主要心脏信号感测电路,感测第二心脏信号的次要心脏信号感测和心律失常检测电路。 主感测电路至少包括第一和第二可植入电极,并且次级感测电路包括用于输送高能量休克疗法的第三可植入电极。 心律失常检测电路使用主感测电路检测快速性心律失常,确定用主感测电路感测的事件与由次级感测电路感测的事件之间的对应关系,并且考虑检测到的节奏是指示噪声还是指示心律失常根据 确定的信件。
    • 2. 发明申请
    • METHOD AND SYSTEM FOR ARRHYTHMIA DISCRIMINATION
    • ARRHYTHMIA歧视的方法与系统
    • WO2014085125A1
    • 2014-06-05
    • PCT/US2013/070564
    • 2013-11-18
    • CARDIAC PACEMAKERS, INC.
    • EBERLE, LeAnne M.PERSCHBACHER, David L.LI, DanBYRNES, Alicia Elaine
    • A61B5/0464A61N1/362
    • A61B5/0464A61B5/0422A61B5/7264A61N1/36114A61N1/3621
    • A method and system for discriminating ventricular arrhythmia is disclosed. In an embodiment, the method can include implementing an arrhythmia discrimination algorithm that can discriminate between supraventricular tachycardia (SVT) and ventricular tachycardia (VT) using at least one programmable parameter programmed to a first value. The method can include analyzing an SVT event, where analyzing the SVT event can include sensing a physiological signal during the SVT event and identifying characteristics of the sensed physiological signal. The method can further include analyzing a cardiac signal to classify the cardiac signal as either an SVT or a VT using the arrhythmia discrimination algorithm with the programmable parameter programmed to a second value. The second value can be determined from the identified characteristics of the sensed physiological signal.
    • 公开了用于区分室性心律失常的方法和系统。 在一个实施例中,该方法可以包括实现心律失常鉴别算法,其可以使用被编程为第一值的至少一个可编程参数来区分室上性心动过速(SVT)和室性心动过速(VT)。 该方法可以包括分析SVT事件,其中分析SVT事件可以包括在SVT事件期间感测生理信号并识别感测到的生理信号的特征。 该方法还可以包括分析心脏信号以将心脏信号分类为SVT或VT,使用心律失常鉴别算法,将可编程参数编程为第二值。 可以根据感测到的生理信号的识别特征来确定第二值。
    • 9. 发明申请
    • USE OF SIGNIFICANT POINT METHODOLOGY TO PREVENT INAPPROPRIATE THERAPY
    • 使用重要的方法来预防不明原因的治疗
    • WO2011088043A1
    • 2011-07-21
    • PCT/US2011/020834
    • 2011-01-11
    • CARDIAC PACEMAKERS, INC.SWEENEY, Robert J.LI, Dan
    • SWEENEY, Robert J.LI, Dan
    • A61N1/365A61N1/39A61B5/00
    • A61N1/36507A61B5/0464A61N1/3925
    • An apparatus example comprises a cardiac signal sensing circuit configured to provide a sensed cardiac signal representative of cardiac depolarization events of a subject, a sampling circuit coupled to the cardiac signal sensing circuit, a therapy circuit, and a controller communicatively coupled to the sampling circuit and the therapy circuit. The controller includes a detection module configured to detect tachyarrhythmia using the cardiac signal and a signal analysis module configured to establish significant points (SPs) of the sampled cardiac signal, estimate heart rate during the tachyarrhythmia using the SPs, and provide an indication of whether noise is present in the cardiac signal using the SPs. The controller is configured to select a therapy for delivery by the therapy circuit in response to the tachyarrhythmia detection and to modify the selected therapy according to the heart rate estimation and the noise indication.
    • 装置示例包括心脏信号感测电路,其被配置为提供表示对象的心脏去极化事件的感测心脏信号,耦合到心脏信号感测电路的采样电路,治疗电路和通信地耦合到采样电路的控制器,以及 治疗电路。 所述控制器包括检测模块,所述检测模块被配置为使用所述心脏信号来检测快速性心律失常;以及信号分析模块,所述信号分析模块被配置为建立所述采集的心脏信号的有效点(SP),使用所述SP在所述快速性心律失常期间估计心率,并且提供噪声 使用SP存在于心脏信号中。 控制器被配置为选择治疗电路响应于快速性心律失常检测的递送的治疗,并且根据心率估计和噪声指示修改所选择的治疗。